Skip to search formSkip to main contentSkip to account menu

aphidicolin glycinate

Known as: AphiG, aphidicolin-17-glycinate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Serum of 336 patients with primary prostate cancer (PC) with baseline total prostate-specific antigen level (totPSA) < 30.0 ng/ml… 
2005
2005
Aphidicolin, a tetracyclic diterpene antibiotic produced by Cephalosporium aphidicola, is under investigation as anti-cancer drug… 
2004
2004
SummaryAphidicolin, a reversible inhibitor of DNA polymerase α and δ, has recently been reported to reverse the resistance to… 
1999
1999
Aphidicolin is a fungal derived tetracyclic diterpene antibiotic. It is selectively toxic for neuroblastoma (NB) cells in vitro… 
1995
1995
The pharmaceutical formulation of a new anti-tumour agent has often been perceived as the bottleneck in anti-cancer drug… 
Highly Cited
1994
Highly Cited
1994
Aphidicolin, an inhibitor of DNA polymerases alpha and delta, is cytotoxic in vitro against tumor cells. The poor solubility of… 
Highly Cited
1991
Highly Cited
1991
The toxicity profile and the pharmacokinetics of aphidicolin glycinate, a water-soluble analogue of aphidicolin, have been… 
1991
1991
Two recently established human ovarian carcinoma cell lines (JA-T and TR175) have been used to study the effects of aphidicolin… 
1990
1990
We examined the effect of specific inhibitors of DNA polymerases alpha and delta, and beta, on cisplatin (DDP) cytotoxicity in… 
1989
1989
A gas chromatographic-mass spectrometric (GC-MS) method is described for the determination of the novel anticancer agent…